Kusaka, Mami
Hasegawa, Tomoko
Ikeda, Hanako Ohashi
Inoue, Yumi
Iwai, Sachiko
Iida, Kei
Tsujikawa, Akitaka
Funding for this research was provided by:
Astellas Foundation for Research on Metabolic Disorders
Japan Foundation for Applied Enzymology
Uehara Memorial Foundation
Mochida Memorial Foundation for Medical and Pharmaceutical Research
Yokoyama Foundation for Clinical Phamacology (YRY1308)
Japan Intractable Diseases Research Foundation
Japan Research Foundation for Clinical Pharmacology
Takeda Science Foundation,Japan
Japan National Society for the Prevention of Blindness
Grant-in-Aid for Young Scientists (24791850)
the Ministry of Health, Labour and Welfare of Japan
Article History
Received: 19 November 2021
Accepted: 14 September 2022
First Online: 28 September 2022
Competing interests
: In relation to this manuscript, Kyoto University applied for patents (PCT/JP2011/067320 and PCT/JP2011/073160) and HOI was one of the inventors of the applied patents. HOI received financial supports by Kyoto Drug Discovery & Development. The other authors declare no competing interest.